Without enabling policies and structural conditions that make local drug manufacturing competitive and sustainable, pharmacists and pharmaceutical manufacturers said Nigeria is unlikely to produce 70 per cent of its essential medicines locally by 2030.

The pharmacists said manufacturers need a stable business environment, reliable energy supply, and access to affordable raw materials to expand production and compete with imported medicines.

They identified high energy and production costs, limited access to financing, and foreign exchange challenges undermining local pharmaceutical production.

The pharmaceutical stakeholders added that despite Federal Government initiatives to boost domestic production, local drug manufacturers continue to grapple with numerous challenges.

The pharmacists spoke exclusively with PUNCH Healthwise on challenges confronting local drug production as the World Health Organisation stated that Nigeria must produce 70 percent of medicines locally by 2030.

The Emir of Kano, Muhammadu Sanusi, in February 2026  declared that 70 percent of drugs Nigerians are consuming are being imported from other countries.

Sanusi, who was the keynote speaker at a conference organised by the Association of Industrial Pharmacists of Nigeria in Lagos, themed ‘Reimagining Nigeria’s Health Security: Local Production, Economic Sovereignty & Strategic Partnership ’, also said 80 percent of imported drugs come from India.

Speaking on the 2030 timeline, the President of the Pharmaceutical Society of Nigeria, Ayuba Tanko, said realities of the pharmaceutical manufacturing environment could make achieving the target impossible.

Tanko

According to him, the target is desirable, necessary, and achievable as a national ambition, but we must be honest about the realities.

Tanko told PUNCH Healthwise that at the current pace, achieving 70 per cent local production by 2030 would be extremely challenging.

“I have previously made this position clear. Ambition without structural reform risks becoming another policy declaration that is not matched by measurable industrial capacity.

“Nigeria has the market, population, pharmaceutical professionals, entrepreneurial capacity and some established manufacturing companies to build a strong domestic pharmaceutical industry. What we have not adequately addressed are the structural conditions that make manufacturing competitive and sustainable,” he said.

WHO Country Representative in Nigeria, Dr Pavel Ursu, in a keynote address at the Academy’s 2026 Annual General Meeting and Investiture of New Fellows in Lagos, delivered on his behalf by the Coordinator, WHO Lagos State, Dr Akinola Fatiregun, stressed the need for Nigeria to reduce its dependence on imported medicines and build a resilient pharmaceutical sector.

He said, “Nigeria needs to strengthen local pharmaceutical manufacturing, reduce dependence on imported medicines and build a resilient pharmaceutical sector capable of safeguarding national health security. The Presidential Initiative for Unlocking the Healthcare Value Chain targets 70 per cent local production of pharmaceuticals by 2030.”

In June 2024, President Bola Tinubu signed an executive order to introduce zero tariffs, excise duties, and value-added tax on imported pharmaceutical products and inputs.

The Coordinating Minister of Health and Social Welfare, Muhammad Ali Pate, who disclosed this, noted that the Executive Order also aims to increase local production of healthcare products.

According to him, the order is crucial to the success of the Presidential Initiative to Unlock the Healthcare Value Chain, approved in October 2023 by Tinubu, which aims to increase local manufacturing of pharmaceutical products in Nigeria to at least 70% by 2030.

While PVAC is designed to strengthen coordination across institutions and accelerate value chain transformation, the Executive Order provides direct incentives for local manufacturing of medicines, syringes, rapid diagnostic test kits and pharmaceutical inputs.

Giving reasons to back his position, the PSN president explained that the country remains heavily dependent on imported Active Pharmaceutical Ingredients, excipients, specialised machinery, packaging materials and other critical production inputs.

He added that manufacturers also contend with high energy costs, foreign exchange volatility, expensive financing, inadequate infrastructure and inconsistent policy implementation.

“We must therefore distinguish between manufacturing finished pharmaceutical formulations locally and achieving genuine pharmaceutical self-sufficiency. A country may manufacture tablets, capsules and syrups locally while importing almost all the critical ingredients required to produce them. That is an important level of industrial development, but it does not amount to complete pharmaceutical sovereignty.

“My position is that Nigeria can make substantial progress towards the 70 per cent target, but achieving it within the 2030 timeline requires a fundamental change in how we approach pharmaceutical industrialisation. We must move from policy pronouncements and isolated incentives to a coordinated national industrial strategy,” he said.

Related News

On what the country should do differently, he listed access to affordable and long-term financing, deliberate investment in local production of APIs and pharmaceutical raw materials, and reliable electricity and dedicated pharmaceutical manufacturing infrastructure.

Others, he said, include predictable government procurement and guaranteed market access, strengthened regulatory capacity and quality assurance, building a skilled pharmaceutical manufacturing workforce, establishing clear and consistent industrial policies, and the government coordinating the entire industrial ecosystem.

“The Presidential Executive Order for the pharmaceutical and allied sectors and PVAC are important interventions, but their success must be measured by actual investments, production capacity, product availability, and reduced import dependence.

“The government must coordinate the entire industrial ecosystem. The Ministries responsible for Health, Finance, Industry, Trade, Investment, Power, Science and Technology, alongside NAFDAC, PCN, CBN and development finance institutions, must work towards a common national objective.

“India and China did not build their pharmaceutical industries through isolated health-sector interventions. They pursued coordinated industrial policies that linked government, finance, research, infrastructure and private enterprise. Nigeria must adopt a similarly integrated approach,” Tanko said.

Also, the National Chairman of the Association of Community Pharmacists of Nigeria, Ambrose Ezeh, said the 2030 target was not realistic.

“How is it going to be feasible when the energy cost and forex rate remain high? With all these and other bottlenecks, how is it going to be achievable by 2030? Ask the people who made that pronouncement how it will happen,” he said.

Ezeh noted that the government knows what to do if the country was really interested in producing 70 per cent of its essential medicines locally.

“The government knows what to do. The government should support pharmaceutical companies. Right now, most pharmaceutical manufacturers use solar as their source of energy, which is not sustainable. Let’s even fix the basics first.

“The country has the Bank of Industry, and nothing is stopping the government from establishing a Bank of Health that can use soft loans to support pharmaceutical companies, so that they can go into mass production and achieve the target. The leadership of the country knows what to do if they really want to achieve that target by 2030,” he said.

The ACPN chairman added, “The exchange rate is high right now; what is the government doing in that regard for manufacturers?

“What of raw materials? Can we get all the raw materials to produce essential medicines here? Common starch, can we produce it locally? APIs are being imported at a high cost. If these things are looked into by the government and we begin to produce those raw materials locally, then it can be achievable.”

Meanwhile, the Executive Secretary and Chief Executive Officer of the Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria, Frank Muonemeh, said the country’s pharmaceutical sector has recorded gains in the last five years.

Muonemeh

“Anyway, the truth is that we have made a lot of progress in the last five years. We are transitioning, and we are making a lot of investments. We are improving our facilities, and we are closing the gap in access to medicines like no other before,” he said.

While commending President Bola Tinubu’s administration for the executive order and PVAC introduced to stimulate local production, he said implementing other favourable policies would help boost local production capacity.

“If we continue on this trajectory, achieving that goal will be a walkover. Today, we can probably say we are taking over 50 per cent of the essential medicines used in Nigeria. 50 per cent of essential medicines in Nigeria are now manufactured locally. It’s not from me; NAFDAC quoted that. It’s NAFDAC data and not mine.

With the right policies, he said the country can achieve the target by 2030.

“So, with the right policy and enabling environment, every other thing will fall into place. And about your question of whether we are going to achieve 70 per cent local manufacturing of essential medicines by 2030, it is a target that is achievable if we continue on this trajectory.

“The government should continue with its right policies, intensify incentives, and come up with more robust policies that will uptake what we manufacture locally,” he said.

Muonemeh urged the FG to optimise health insurance coverage, ensure access to finance at lower rates, and close the gap in infrastructural deficits.

“Everything falls under policy, and after policy, the next thing is access to finance. You cannot run any business with the kind of interest rates we are having.

“Also, about 40 per cent of our manufacturing cost is spent on energy costs, and when you compare with other countries in Asia, they don’t spend up to 10 per cent,” the PMG-MAN executive secretary said.

Source: Punch · Idowu Abdullahi

At a glance

Topic
World
Country
🇳🇬 NG
Publisher language
EN
Added to Allnira